0001752724-22-072286.txt : 20220325
0001752724-22-072286.hdr.sgml : 20220325
20220325123559
ACCESSION NUMBER: 0001752724-22-072286
CONFORMED SUBMISSION TYPE: NPORT-P
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20220131
FILED AS OF DATE: 20220325
PERIOD START: 20221031
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: T. Rowe Price Global Funds, Inc.
CENTRAL INDEX KEY: 0000852254
IRS NUMBER: 000000000
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: NPORT-P
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-05833
FILM NUMBER: 22769591
BUSINESS ADDRESS:
STREET 1: 100 EAST PRATT STREET
CITY: BALTIMORE
STATE: MD
ZIP: 21202
BUSINESS PHONE: 410-345-2000
MAIL ADDRESS:
STREET 1: 100 EAST PRATT STREET
CITY: BALTIMORE
STATE: MD
ZIP: 21202
FORMER COMPANY:
FORMER CONFORMED NAME: T. Rowe Price Institutional International Funds, Inc.
DATE OF NAME CHANGE: 20051028
FORMER COMPANY:
FORMER CONFORMED NAME: T ROWE PRICE INSTITUTIONAL INTERNATIONAL FUNDS INC
DATE OF NAME CHANGE: 20011217
FORMER COMPANY:
FORMER CONFORMED NAME: INSTITUTIONAL INTERNATIONAL FUNDS INC
DATE OF NAME CHANGE: 19920703
0000852254
S000029530
T. Rowe Price Institutional International Disciplined Equity Fund
C000090615
T. Rowe Price Institutional International Disciplined Equity Fund
RPICX
NPORT-P
1
primary_doc.xml
NPORT-P
false
0000852254
XXXXXXXX
S000029530
C000090615
T. ROWE PRICE GLOBAL FUNDS, INC.
811-05833
0000852254
5493007HG7742XS78J80
100 East Pratt Street
Baltimore
21202
410-345-2000
T. Rowe Price Institutional International Disciplined Equity Fund
S000029530
7D4X82TRE4PUE27U6W16
2022-10-31
2022-01-31
N
369145930.81
2062995.72
367082935.09
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
87119.71000000
N
Siemens AG
W38RGI023J3WT1HWRP32
Siemens AG
000000000
29022.00000000
NS
4607857.67000000
1.255263383156
Long
EC
CORP
DE
N
2
N
N
N
Alibaba Group Holding Ltd
5493001NTNQJDH60PM02
Alibaba Group Holding Ltd
01609W102
33400.00000000
NS
USD
4201386.00000000
1.144533182663
Long
EC
CORP
CN
N
1
N
N
N
Barry Callebaut AG
213800Y5RWKLDPUTT265
Barry Callebaut AG
000000000
2335.00000000
NS
5360292.42000000
1.460240154908
Long
EC
CORP
CH
N
2
N
N
N
Smiths Group PLC
213800MJL6IPZS3ASA11
Smiths Group PLC
000000000
239826.00000000
NS
5054954.95000000
1.377060731183
Long
EC
CORP
GB
N
2
N
N
N
EXOR NV
5493002ENHZ6NYET7405
EXOR NV
000000000
68190.00000000
NS
5717792.83000000
1.557629702562
Long
EC
CORP
NL
N
2
N
N
N
SoftBank Group Corp
5493003BZYYYCDIO0R13
SoftBank Group Corp
000000000
115200.00000000
NS
5103307.41000000
1.390232811761
Long
EC
CORP
JP
N
2
N
N
N
Muenchener Rueckversicherungs-Gesellschaft AG in Muenchen
529900MUF4C20K50JS49
Muenchener Rueckversicherungs-Gesellschaft AG in Muenchen
000000000
16153.00000000
NS
5113796.87000000
1.393090329504
Long
EC
CORP
DE
N
2
N
N
N
Hoya Corp
353800X4VR3BHEUCJB42
Hoya Corp
000000000
25500.00000000
NS
3306542.80000000
0.900761785395
Long
EC
CORP
JP
N
2
N
N
N
Mitsubishi Electric Corp
549300TRXM9Y6561AX39
Mitsubishi Electric Corp
000000000
463500.00000000
NS
5804596.31000000
1.581276533210
Long
EC
CORP
JP
N
2
N
N
N
Heineken NV
724500K5PTPSST86UQ23
Heineken NV
000000000
49436.00000000
NS
5301843.82000000
1.444317704036
Long
EC
CORP
NL
N
2
N
N
N
Industrivarden AB
549300TM1DLIQI3B3T37
Industrivarden AB
000000000
189443.00000000
NS
5884213.06000000
1.602965569226
Long
EC
CORP
SE
N
2
N
N
N
Beiersdorf AG
L47NHHI0Z9X22DV46U41
Beiersdorf AG
000000000
50843.00000000
NS
5057022.83000000
1.377624058922
Long
EC
CORP
DE
N
2
N
N
N
Amcor PLC
549300GSODGFCDQ3DI89
Amcor PLC
000000000
332722.00000000
NS
3986865.77000000
1.086094010069
Long
EC
CORP
GB
N
2
N
N
N
Henkel AG & Co KGaA
549300VZCL1HTH4O4Y49
Henkel AG & Co KGaA
000000000
66374.00000000
NS
5428627.17000000
1.478855771017
Long
EP
CORP
DE
N
2
N
N
N
Kirin Holdings Co Ltd
353800GBVL72LLMTYM96
Kirin Holdings Co Ltd
497350108
364800.00000000
NS
5847067.02000000
1.592846319202
Long
EC
CORP
JP
N
2
N
N
N
L E Lundbergforetagen AB
529900BPSFZS6O3A9R04
L E Lundbergforetagen AB
000000000
115814.00000000
NS
5917699.43000000
1.612087859259
Long
EC
CORP
SE
N
2
N
N
N
GlaxoSmithKline PLC
5493000HZTVUYLO1D793
GlaxoSmithKline PLC
000000000
108505.00000000
NS
2421398.21000000
0.659632464093
Long
EC
CORP
GB
N
2
N
N
N
T. ROWE PRICE GOVERNMENT RESERVE FUND
5493002Y0IYARJVQ5N24
T. ROWE PRICE GOVERNMENT RESERVE FUND
76105Y109
20898003.04000000
NS
USD
20898003.04000000
5.692992248434
Long
STIV
RF
US
N
1
N
N
N
Koninklijke Vopak NV
724500UL634GFV1KYF10
Koninklijke Vopak NV
000000000
158429.00000000
NS
5435837.93000000
1.480820111854
Long
EC
CORP
NL
N
2
N
N
N
Unilever PLC
549300MKFYEKVRWML317
Unilever PLC
000000000
102594.00000000
NS
5240221.26000000
1.427530609319
Long
EC
CORP
GB
N
2
N
N
N
BASF SE
529900PM64WH8AF1E917
BASF SE
000000000
68406.00000000
NS
5239140.51000000
1.427236193563
Long
EC
CORP
DE
N
2
N
N
N
H Lundbeck A/S
5493006R4KC2OI5D3470
H Lundbeck A/S
000000000
166352.00000000
NS
4232654.50000000
1.153051284980
Long
EC
CORP
DK
N
2
N
N
N
Schneider Electric SE
969500A1YF1XUYYXS284
Schneider Electric SE
000000000
23123.00000000
NS
3916930.15000000
1.067042288152
Long
EC
CORP
FR
N
2
N
N
N
HSBC Holdings PLC
MLU0ZO3ML4LN2LL2TL39
HSBC Holdings PLC
000000000
747199.00000000
NS
5318073.00000000
1.448738824836
Long
EC
CORP
GB
N
2
N
N
N
Sprott Physical Gold and Silver Trust
N/A
Sprott Physical Gold and Silver Trust
85208R101
346760.00000000
NS
USD
6012818.40000000
1.637999979085
Long
EC
RF
CA
N
1
N
N
N
Red Electrica Corp SA
5493009HMD0C90GUV498
Red Electrica Corp SA
000000000
199900.00000000
NS
4029629.26000000
1.097743554603
Long
EC
CORP
ES
N
2
N
N
N
ASML Holding NV
724500Y6DUVHQD6OXN27
ASML Holding NV
000000000
9575.00000000
NS
6485093.28000000
1.766656158617
Long
EC
CORP
NL
N
2
N
N
N
Great Portland Estates PLC
213800JMEDD2Q4N1MC42
Great Portland Estates PLC
000000000
400866.00000000
NS
4153353.51000000
1.131448267673
Long
EC
CORP
GB
N
2
N
N
N
Suntory Beverage & Food Ltd
549300FONLMVK7YYYH41
Suntory Beverage & Food Ltd
000000000
145800.00000000
NS
5598531.47000000
1.525140761072
Long
EC
CORP
JP
N
2
N
N
N
Koninklijke Philips NV
H1FJE8H61JGM1JSGM897
Koninklijke Philips NV
000000000
165174.00000000
NS
5494230.49000000
1.496727296422
Long
EC
CORP
NL
N
2
N
N
N
Otsuka Holdings Co Ltd
N/A
Otsuka Holdings Co Ltd
000000000
170400.00000000
NS
5813594.74000000
1.583727867538
Long
EC
CORP
JP
N
2
N
N
N
Continental AG
529900A7YD9C0LLXM621
Continental AG
000000000
55996.00000000
NS
5428819.35000000
1.478908124309
Long
EC
CORP
DE
N
2
N
N
N
Novartis AG
5493007HIVTX6SY6XD66
Novartis AG
000000000
69358.00000000
NS
6026485.49000000
1.641723140445
Long
EC
CORP
CH
N
2
N
N
N
Iberdrola SA
N/A
Iberdrola SA
000000000
7051.95000000
NS
80492.73000000
0.021927668737
Long
EC
CORP
ES
N
2
N
N
N
Metso Outotec Oyj
549300R0VN9C371W0E07
Metso Outotec Oyj
000000000
232515.00000000
NS
2493632.08000000
0.679310270685
Long
EC
CORP
FI
N
2
N
N
N
Roche Holding AG
549300U41AUUVOAAOB37
Roche Holding AG
000000000
15473.00000000
NS
5988041.44000000
1.631250289129
Long
EC
CORP
CH
N
2
N
N
N
Wendel SE
969500M98ZMIZYJD5O34
Wendel SE
000000000
51871.00000000
NS
5634038.71000000
1.534813572474
Long
EC
CORP
FR
N
2
N
N
N
Smith & Nephew PLC
213800ZTMDN8S67S1H61
Smith & Nephew PLC
000000000
324848.00000000
NS
5524682.85000000
1.505023067510
Long
EC
CORP
GB
N
2
N
N
N
Groupe Bruxelles Lambert SA
549300KV0ZEHT2KVU152
Groupe Bruxelles Lambert SA
000000000
57007.00000000
NS
6117015.42000000
1.666385123160
Long
EC
CORP
BE
N
2
N
N
N
Prosus NV
635400Z5LQ5F9OLVT688
Prosus NV
000000000
48623.00000000
NS
4045231.99000000
1.101994019146
Long
EC
CORP
NL
N
2
N
N
N
Thales SA
529900FNDVTQJOVVPZ19
Thales SA
000000000
59936.00000000
NS
5528942.49000000
1.506183470131
Long
EC
CORP
FR
N
2
N
N
N
Verallia SA
5299007YZU978DE0ZY32
Verallia SA
000000000
189291.00000000
NS
5937088.88000000
1.617369894502
Long
EC
CORP
FR
N
2
N
N
N
Rolls-Royce Holdings PLC
213800EC7997ZBLZJH69
Rolls-Royce Holdings PLC
000000000
2255313.00000000
NS
3535160.75000000
0.963041430714
Long
EC
CORP
GB
N
2
N
N
N
Japan Tobacco Inc
353800Z0ENYBQO0XRJ31
Japan Tobacco Inc
000000000
194600.00000000
NS
3885166.14000000
1.058389199990
Long
EC
CORP
JP
N
2
N
N
N
Astellas Pharma Inc
529900IB708DY2HBBB35
Astellas Pharma Inc
000000000
256300.00000000
NS
4136829.27000000
1.126946767216
Long
EC
CORP
JP
N
2
N
N
N
Iberdrola SA
5QK37QC7NWOJ8D7WVQ45
Iberdrola SA
000000000
468833.00000000
NS
5375201.27000000
1.464301594047
Long
EC
CORP
ES
N
2
N
N
N
Definity Financial Corp
984500D5F3FC49D00C44
Definity Financial Corp
24477T100
33307.00000000
NS
755149.07000000
0.205716201385
Long
EC
CORP
CA
N
2
N
N
N
Deutsche Telekom AG
549300V9QSIG4WX4GJ96
Deutsche Telekom AG
000000000
234555.00000000
NS
4428160.21000000
1.206310560013
Long
EC
CORP
DE
N
2
N
N
N
Investor AB
549300VEBQPHRZBKUX38
Investor AB
000000000
274090.00000000
NS
5951023.60000000
1.621165963092
Long
EC
CORP
SE
N
2
N
N
N
Ayala Corp
254900QJ68UH8GKNGI69
Ayala Corp
000000000
326250.00000000
NS
5578969.03000000
1.519811600240
Long
EC
CORP
PH
N
2
N
N
N
BAE Systems PLC
8SVCSVKSGDWMW2QHOH83
BAE Systems PLC
000000000
656533.00000000
NS
5137869.15000000
1.399648051942
Long
EC
CORP
GB
N
2
N
N
N
National Grid PLC
8R95QZMKZLJX5Q2XR704
National Grid PLC
000000000
250969.00000000
NS
3672412.73000000
1.000431340971
Long
EC
CORP
GB
N
2
N
N
N
Amadeus IT Group SA
9598004A3FTY3TEHHN09
Amadeus IT Group SA
000000000
75025.00000000
NS
5158736.15000000
1.405332598404
Long
EC
CORP
ES
N
2
N
N
N
Nestle SA
KY37LUS27QQX7BB93L28
Nestle SA
000000000
46850.00000000
NS
6050132.91000000
1.648165123371
Long
EC
CORP
CH
N
2
N
N
N
JCDecaux SA
9695009KV7AFPDEI5S30
JCDecaux SA
000000000
115554.00000000
NS
3163190.10000000
0.861709929181
Long
EC
CORP
FR
N
2
N
N
N
TotalEnergies SE
529900S21EQ1BO4ESM68
TotalEnergies SE
000000000
83291.00000000
NS
4736547.29000000
1.290320752404
Long
EC
CORP
FR
N
2
N
N
N
Deutsche Boerse AG
529900G3SW56SHYNPR95
Deutsche Boerse AG
000000000
11982.00000000
NS
2129829.79000000
0.580203977468
Long
EC
CORP
DE
N
2
N
N
N
BHP Group Ltd
WZE1WSENV6JSZFK0JC28
BHP Group Ltd
Q1498M100
121384.00000000
NS
3831462.05000000
1.043759239056
Long
EC
CORP
AU
N
2
N
N
N
Bayer AG
549300J4U55H3WP1XT59
Bayer AG
000000000
67244.00000000
NS
4085332.31000000
1.112918068228
Long
EC
CORP
DE
N
2
N
N
N
Millicom International Cellula
549300CTHC1CP86P2G96
Millicom International Cellular SA
000000000
190684.00000000
NS
5090089.32000000
1.386631966084
Long
EC
CORP
LU
N
2
N
N
N
Kojamo Oyj
7437007YPUOQZ8OV1R42
Kojamo Oyj
000000000
228547.00000000
NS
5239647.65000000
1.427374347629
Long
EC
CORP
FI
N
2
N
N
N
CK Hutchison Holdings Ltd
254900Z8HM1VEPOQ2G79
CK Hutchison Holdings Ltd
000000000
952692.00000000
NS
6771091.03000000
1.844567094446
Long
EC
CORP
HK
N
2
N
N
N
Hoshizaki Corp
5299001QAMLGU3SRBG20
Hoshizaki Corp
000000000
76000.00000000
NS
5615977.61000000
1.529893403686
Long
EC
CORP
JP
N
2
N
N
N
NTT
353800VHQU5VIXVUA841
Nippon Telegraph & Telephone Corp
000000000
148500.00000000
NS
4249733.40000000
1.157703884806
Long
EC
CORP
JP
N
2
N
N
N
Burberry Group PLC
213800PE1KEFCNFR1R50
Burberry Group PLC
000000000
238083.00000000
NS
6039919.50000000
1.645382806618
Long
EC
CORP
GB
N
2
N
N
N
Sampo Oyj
743700UF3RL386WIDA22
Sampo Oyj
000000000
89100.00000000
NS
4422285.68000000
1.204710232284
Long
EC
CORP
FI
N
2
N
N
N
EssilorLuxottica SA
549300M3VH1A3ER1TB49
EssilorLuxottica SA
000000000
24556.00000000
NS
4645636.75000000
1.265555084673
Long
EC
CORP
FR
N
2
N
N
N
Knorr-Bremse AG
5299001GRRO0Z25YZT52
Knorr-Bremse AG
000000000
51120.00000000
NS
5183040.38000000
1.411953508198
Long
EC
CORP
DE
N
2
N
N
N
Sanofi
549300E9PC51EN656011
Sanofi
000000000
52680.00000000
NS
5508328.31000000
1.500567796388
Long
EC
CORP
FR
N
2
N
N
N
Mitsubishi Corp
KVIPTY4PULAPGC1VVD26
Mitsubishi Corp
000000000
163400.00000000
NS
5547828.16000000
1.511328266632
Long
EC
CORP
JP
N
2
N
N
N
Shimano Inc
529900L32YT3P9DECR10
Shimano Inc
000000000
20000.00000000
NS
4484842.83000000
1.221751926141
Long
EC
CORP
JP
N
2
N
N
N
HAL Trust
5493000O3IE3DNOY3R07
HAL Trust
000000000
36675.00000000
NS
5754118.66000000
1.567525512617
Long
EC
CORP
CW
N
2
N
N
N
2022-03-24
T. ROWE PRICE GLOBAL FUNDS, INC.
Alan S. Dupski
Alan S. Dupski
Treasurer & Vice President
XXXX
NPORT-EX
2
70AQTRP013122.htm
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
January
31,
2022
(Unaudited)
Portfolio
of
Investments
‡
Shares
$
Value
(
Cost
and
value
in
$000s)
‡
AUSTRALIA
1.1%
Common
Stocks
1.1%
BHP
Group
(GBP)
121,384
3,831
Total
Australia
(Cost
$1,271
)
3,831
BELGIUM
1.7%
Common
Stocks
1.7%
Groupe
Bruxelles
Lambert
57,007
6,117
Total
Belgium
(Cost
$4,598
)
6,117
CANADA
1.9%
Common
Stocks
1.9%
Definity
Financial (1)
33,307
755
Sprott
Physical
Gold
&
Silver
Trust
(USD) (1)
346,760
6,013
Total
Canada
(Cost
$6,020
)
6,768
CHINA
1.0%
Common
Stocks
1.0%
Alibaba
Group
Holding,
ADR
(USD) (1)
29,000
3,648
Total
China
(Cost
$4,792
)
3,648
DENMARK
1.2%
Common
Stocks
1.2%
H
Lundbeck
166,352
4,233
Total
Denmark
(Cost
$5,131
)
4,233
FINLAND
3.2%
Common
Stocks
3.2%
Kojamo
228,547
5,240
Metso
Outotec
169,796
1,821
Sampo,
Class
A
89,100
4,422
Total
Finland
(Cost
$9,092
)
11,483
FRANCE
10.8%
Common
Stocks
10.8%
EssilorLuxottica
24,556
4,646
JCDecaux (1)
103,465
2,832
Sanofi
52,680
5,508
Schneider
Electric
23,123
3,917
Thales
59,936
5,529
TotalEnergies
83,291
4,737
Verallia
189,291
5,937
Wendel
51,871
5,634
Total
France
(Cost
$31,986
)
38,740
Shares
$
Value
(Cost
and
value
in
$000s)
GERMANY
13.0%
Common
Stocks
11.5%
BASF
68,406
5,239
Bayer
66,028
4,011
Beiersdorf
51,208
5,093
Continental (1)
55,996
5,429
Deutsche
Boerse
11,982
2,130
Deutsche
Telekom
234,555
4,428
Knorr-Bremse
51,120
5,183
Munich
Re
16,153
5,114
Siemens
29,022
4,608
41,235
Preferred
Stocks
1.5%
Henkel
66,374
5,429
5,429
Total
Germany
(Cost
$45,314
)
46,664
HONG
KONG
1.9%
Common
Stocks
1.9%
CK
Hutchison
Holdings
952,692
6,771
Total
Hong
Kong
(Cost
$7,387
)
6,771
ITALY
1.6%
Common
Stocks
1.6%
EXOR
68,190
5,718
Total
Italy
(Cost
$4,471
)
5,718
JAPAN
16.5%
Common
Stocks
16.5%
Astellas
Pharma
256,300
4,137
Hoshizaki
76,000
5,616
Hoya
25,500
3,306
Japan
Tobacco
194,600
3,885
Kirin
Holdings
364,800
5,847
Mitsubishi
163,400
5,548
Mitsubishi
Electric
463,500
5,805
Nippon
Telegraph
&
Telephone
148,500
4,250
Otsuka
Holdings
170,400
5,814
Shimano
20,000
4,485
SoftBank
Group
115,200
5,103
Suntory
Beverage
&
Food
145,800
5,598
Total
Japan
(Cost
$55,820
)
59,394
NETHERLANDS
9.0%
Common
Stocks
9.0%
ASML
Holding
9,575
6,485
HAL
Trust
36,675
5,754
Heineken
50,786
5,447
Koninklijke
Philips
165,174
5,494
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
Shares
$
Value
(Cost
and
value
in
$000s)
Koninklijke
Vopak
158,429
5,436
Prosus
44,068
3,666
Total
Netherlands
(Cost
$29,757
)
32,282
PHILIPPINES
1.5%
Common
Stocks
1.5%
Ayala
326,250
5,579
Total
Philippines
(Cost
$5,571
)
5,579
SPAIN
4.1%
Common
Stocks
4.1%
Amadeus
IT
Group,
Class
A (1)
76,262
5,244
Iberdrola (1)
7,052
80
Iberdrola
468,833
5,375
Red
Electrica
199,900
4,030
Total
Spain
(Cost
$13,055
)
14,729
SWEDEN
6.4%
Common
Stocks
6.4%
Industrivarden,
Class
C
189,443
5,884
Investor,
Class
B
274,090
5,951
L
E
Lundbergforetagen,
Class
B
115,814
5,918
Millicom
International
Cellular,
SDR (1)
192,071
5,127
Total
Sweden
(Cost
$21,488
)
22,880
SWITZERLAND
6.5%
Common
Stocks
6.5%
Barry
Callebaut
2,335
5,360
Shares
$
Value
(Cost
and
value
in
$000s)
Nestle
46,850
6,050
Novartis
69,358
6,027
Roche
Holding
15,473
5,988
Total
Switzerland
(Cost
$16,906
)
23,425
UNITED
KINGDOM
14.0%
Common
Stocks
14.0%
Amcor,
CDI
(AUD)
332,722
3,987
BAE
Systems
656,533
5,138
Burberry
Group
238,083
6,040
GlaxoSmithKline
108,505
2,421
Great
Portland
Estates
400,866
4,153
HSBC
Holdings
747,199
5,318
National
Grid
250,969
3,673
Rolls-Royce
Holdings (1)
2,255,313
3,535
Smith
&
Nephew
324,848
5,525
Smiths
Group
239,826
5,055
Unilever
(EUR)
106,846
5,457
Total
United
Kingdom
(Cost
$43,280
)
50,302
SHORT-TERM
INVESTMENTS
5.8%
Money
Market
Funds
5.8%
T.
Rowe
Price
Government
Reserve
Fund,
0.09% (2)(3)
20,899,120
20,899
Total
Short-Term
Investments
(Cost
$20,899)
20,899
Total
Investments
in
Securities
101.2%
(Cost
$326,838)
$
363,463
Other
Assets
Less
Liabilities
(1.2)%
(4,136)
Net
Assets
100.0%
$
359,327
‡
Country
classifications
are
generally
based
on
MSCI
categories
or
another
unaffiliated
third
party
data
provider;
Shares
are
denominated
in
the
currency
of
the
country
presented
unless
otherwise
noted.
(1)
Non-income
producing
(2)
Seven-day
yield
(3)
Affiliated
Companies
ADR
American
Depositary
Receipts
AUD
Australian
Dollar
CDI
CHESS
or
CREST
Depositary
Interest
EUR
Euro
GBP
British
Pound
SDR
Swedish
Depository
Receipts
USD
U.S.
Dollar
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
The
accompanying
notes
are
an
integral
part
of
this
Portfolio
of
Investments.
AFFILIATED
COMPANIES
($000s)
The
fund
may
invest
in
certain
securities
that
are
considered
affiliated
companies.
As
defined
by
the
1940
Act,
an
affiliated
company
is
one
in
which
the
fund
owns
5%
or
more
of
the
outstanding
voting
securities,
or
a
company
that
is
under
common
ownership
or
control.
The
following
securities
were
considered
affiliated
companies
for
all
or
some
portion
of
the
three
months
ended
January
31,
2022.
Net
realized
gain
(loss),
investment
income,
change
in
net
unrealized
gain/loss,
and
purchase
and
sales
cost
reflect
all
activity
for
the
period
then
ended.
Affiliate
Net
Realized
Gain
(Loss)
Change
in
Net
Unrealized
Gain/Loss
Investment
Income
T.
Rowe
Price
Government
Reserve
Fund,
0.09%
$
—#
$
—
$
4+
Supplementary
Investment
Schedule
Affiliate
Value
10/31/21
Purchase
Cost
Sales
Cost
Value
01/31/22
T.
Rowe
Price
Government
Reserve
Fund,
0.09%
$
31,270
¤
¤
$
20,899^
#
Capital
gain
distributions
from
mutual
funds
represented
$0
of
the
net
realized
gain
(loss).
+
Investment
income
comprised
$4
of
dividend
income
and
$0
of
interest
income.
¤
Purchase
and
sale
information
not
shown
for
cash
management
funds.
^
The
cost
basis
of
investments
in
affiliated
companies
was
$20,899.
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
Unaudited
Notes
to
Portfolio
of
Investments
T.
Rowe
Price
Institutional
International
Disciplined
Equity
Fund (the
fund) is
registered
under
the
Investment
Company
Act
of
1940
(the
1940
Act)
as
an
open-end
management
investment
company
and
follows
accounting
and
reporting
guidance
of
the
Financial
Accounting
Standards
Board
Accounting
Standards
Codification
Topic
946.
The
accompanying
Portfolio
of
Investments
was
prepared
in
accordance
with
accounting
principles
generally
accepted
in
the
United
States
of
America
(GAAP).
For
additional
information
on
the
fund’s
significant
accounting
policies
and
investment
related
disclosures,
please
refer
to
the
fund’s most
recent
semiannual
or
annual
shareholder
report
and
its
prospectus.
VALUATION
Fair
Value
The
fund’s
financial
instruments
are
valued
at
the
close
of
the
New
York
Stock
Exchange
(NYSE),
normally
4
p.m.
ET,
each
day
the
NYSE
is
open
for
business,
and
are
reported
at
fair
value,
which
GAAP
defines
as
the
price
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
at
the
measurement
date. The
T.
Rowe
Price
Valuation
Committee
(the
Valuation
Committee)
is
an
internal
committee
that
has
been
delegated
certain
responsibilities
by
the
fund’s
Board
of
Directors
(the
Board)
to
ensure
that
financial
instruments
are
appropriately
priced
at
fair
value
in
accordance
with
GAAP
and
the
1940
Act.
Subject
to
oversight
by
the
Board,
the
Valuation
Committee
develops
and
oversees
pricing-related
policies
and
procedures
and
approves
all
fair
value
determinations.
Specifically,
the
Valuation
Committee
establishes
policies
and
procedures
used
in
valuing
financial
instruments,
including
those
which
cannot
be
valued
in
accordance
with
normal
procedures
or
using
pricing
vendors;
determines
pricing
techniques,
sources,
and
persons
eligible
to
effect
fair
value
pricing
actions;
evaluates
the
services
and
performance
of
the
pricing
vendors;
oversees
the
pricing
process
to
ensure
policies
and
procedures
are
being
followed;
and
provides
guidance
on
internal
controls
and
valuation-related
matters.
The
Valuation
Committee
provides
periodic
reporting
to
the
Board
on
valuation
matters.
Various
valuation
techniques
and
inputs
are
used
to
determine
the
fair
value
of
financial
instruments.
GAAP
establishes
the
following
fair
value
hierarchy
that
categorizes
the
inputs
used
to
measure
fair
value:
Level
1
–
quoted
prices
(unadjusted)
in
active
markets
for
identical
financial
instruments
that
the
fund
can
access
at
the
reporting
date
Level
2
–
inputs
other
than
Level
1
quoted
prices
that
are
observable,
either
directly
or
indirectly
(including,
but
not
limited
to,
quoted
prices
for
similar
financial
instruments
in
active
markets,
quoted
prices
for
identical
or
similar
financial
instruments
in
inactive
markets,
interest
rates
and
yield
curves,
implied
volatilities,
and
credit
spreads)
Level
3
–
unobservable
inputs
(including
the fund’s
own
assumptions
in
determining
fair
value)
Observable
inputs
are
developed
using
market
data,
such
as
publicly
available
information
about
actual
events
or
transactions,
and
reflect
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
Unobservable
inputs
are
those
for
which
market
data
are
not
available
and
are
developed
using
the
best
information
available
about
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
GAAP
requires
valuation
techniques
to
maximize
the
use
of
relevant
observable
inputs
and
minimize
the
use
of
unobservable
inputs.
When
multiple
inputs
are
used
to
derive
fair
value,
the
financial
instrument
is
assigned
to
the
level
within
the
fair
value
hierarchy
based
on
the
lowest-level
input
that
is
significant
to
the
fair
value
of
the
financial
instrument.
Input
levels
are
not
necessarily
an
indication
of
the
risk
or
liquidity
associated
with
financial
instruments
at
that
level
but
rather
the
degree
of
judgment
used
in
determining
those
values.
Valuation
Techniques
Equity
securities,
including
exchange-traded
funds, listed
or
regularly
traded
on
a
securities
exchange
or
in
the
over-the-counter
(OTC)
market
are
valued
at
the
last
quoted
sale
price
or,
for
certain
markets,
the
official
closing
price
at
the
time
the
valuations
are
made.
OTC
Bulletin
Board
securities
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices.
A
security
that
is
listed
or
traded
on
more
than
one
exchange
is
valued
at
the
quotation
on
the
exchange
determined
to
be
the
primary
market
for
such
security.
Listed
securities
not
traded
on
a
particular
day
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices
for
domestic
securities
and
the
last
quoted
sale
or
closing
price
for
international
securities.
The
last
quoted
prices
of
non-U.S.
equity
securities
may
be
adjusted
to
reflect
the
fair
value
of
such
securities
at
the
close
of
the
NYSE,
if
the
fund
determines
that
developments
between
the
close
of
a
foreign
market
and
the
close
of
the
NYSE
will
affect
the
value
of
some
or
all
of
its
portfolio
securities.
Each
business
day,
the
fund
uses
information
from
outside
pricing
services
to
evaluate
and,
if
appropriate,
decide whether
it
is
necessary
to
adjust
quoted
prices
to
reflect
fair
value
by
reviewing
a
variety
of
factors,
including
developments
T.
ROWE
PRICE
Institutional
International
Disciplined
Equity
Fund
in
foreign
markets,
the
performance
of
U.S.
securities
markets,
and
the
performance
of
instruments
trading
in
U.S.
markets
that
represent
foreign
securities
and
baskets
of
foreign
securities. The
fund
uses
outside
pricing
services
to
provide
it
with
quoted
prices
and
information
to
evaluate
or
adjust
those
prices.
The
fund
cannot
predict
how
often
it
will
use
quoted
prices
and
how
often
it
will
determine
it
necessary
to
adjust
those
prices
to
reflect
fair
value.
Investments
denominated
in
foreign
currencies
are
translated
into
U.S.
dollar
values
each
day
at
the
prevailing
exchange
rate,
using
the
mean
of
the
bid
and
asked
prices
of
such
currencies
against
U.S.
dollars
as
provided
by
an
outside
pricing
service.
Investments
in
mutual
funds
are
valued
at
the
mutual
fund’s
closing
NAV
per
share
on
the
day
of
valuation.
Investments
for
which
market
quotations
or
market-based
valuations
are
not
readily
available
or
deemed
unreliable
are
valued
at
fair
value
as
determined
in
good
faith
by
the
Valuation
Committee,
in
accordance
with
fair
valuation
policies
and
procedures.
The
objective
of
any
fair
value
pricing
determination
is
to
arrive
at
a
price
that
could
reasonably
be
expected
from
a
current
sale.
Financial
instruments
fair
valued
by
the
Valuation
Committee
are
primarily
private
placements,
restricted
securities,
warrants,
rights,
and
other
securities
that
are
not
publicly
traded.
Factors
used
in
determining
fair
value
vary
by
type
of
investment
and
may
include
market
or
investment
specific
considerations.
The
Valuation
Committee
typically
will
afford
greatest
weight
to
actual
prices
in
arm’s
length
transactions,
to
the
extent
they
represent
orderly
transactions
between
market
participants,
transaction
information
can
be
reliably
obtained,
and
prices
are
deemed
representative
of
fair
value.
However,
the
Valuation
Committee
may
also
consider
other
valuation
methods
such
as
market-based
valuation
multiples;
a
discount
or
premium
from
market
value
of
a
similar,
freely
traded
security
of
the
same
issuer;
discounted
cash
flows;
yield
to
maturity;
or
some
combination.
Fair
value
determinations
are
reviewed
on
a
regular
basis
and
updated
as
information
becomes
available,
including
actual
purchase
and
sale
transactions
of
the
investment.
Because
any
fair
value
determination
involves
a
significant
amount
of
judgment,
there
is
a
degree
of
subjectivity
inherent
in
such
pricing
decisions,
and
fair
value
prices
determined
by
the
Valuation
Committee
could
differ
from
those
of
other
market
participants.
Valuation
Inputs
The
following
table
summarizes
the
fund’s
financial
instruments,
based
on
the
inputs
used
to
determine
their
fair
values
on
January
31,
2022
(for
further
detail
by
category,
please
refer
to
the
accompanying
Portfolio
of
Investments):
SUBSEQUENT
EVENT
In
February
2022,
Russian
forces
entered
Ukraine
and
commenced
an
armed
conflict.
Economic
sanctions
have
since
been
imposed
on
Russia
and
certain
of
its
citizens,
including
the
exclusion
of
Russia
from
the
SWIFT
global
payments
network.
As
a
result,
Russia’s
central
bank
closed
the
country’s
stock
market
on
February
28,
2022,
and
Russian-related
stocks
and
debt
and
the
Russian
ruble
have
since
suffered
significant
declines
in
value.
In
addition,
this
armed
conflict
and
the
related
sanctions
may
cause
significant
disruptions
to
global
business
activity
and
volatility
in
global
financial
markets.
The
duration
of
the
conflict
and
related
economic
sanctions
and
their
effects
on
the
financial
markets
cannot
be
determined
with
certainty.
The
fund’s
performance
could
be
negatively
impacted
if
the
value
of
a
portfolio
holding
were
harmed
by
such
events.
Management
is
actively
monitoring
these
events.
E177-054Q1
01/22
($000s)
Level
1
Level
2
Level
3
Total
Value
Assets
Common
Stocks
$
9,661
$
327,474
$
—
$
337,135
Preferred
Stocks
—
5,429
—
5,429
Short-Term
Investments
20,899
—
—
20,899
Total
$
30,560
$
332,903
$
—
$
363,463